Callan JMB Inc. (NASDAQ:CJMB – Get Free Report) CEO Wayne Williams acquired 10,810 shares of the firm’s stock in a transaction on Monday, December 15th. The stock was purchased at an average cost of $1.70 per share, for a total transaction of $18,377.00. Following the completion of the acquisition, the chief executive officer owned 79,355 shares in the company, valued at approximately $134,903.50. This represents a 15.77% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Callan JMB Price Performance
Callan JMB stock traded down $0.07 during midday trading on Monday, hitting $1.71. The company’s stock had a trading volume of 39,741 shares, compared to its average volume of 45,032. The company has a 50-day moving average price of $3.34 and a two-hundred day moving average price of $4.34. Callan JMB Inc. has a 1-year low of $1.20 and a 1-year high of $7.76.
Callan JMB (NASDAQ:CJMB – Get Free Report) last released its quarterly earnings results on Friday, November 14th. The company reported ($0.61) earnings per share for the quarter. Callan JMB had a negative net margin of 112.72% and a negative return on equity of 133.43%. The business had revenue of $1.45 million during the quarter.
Analyst Upgrades and Downgrades
Check Out Our Latest Research Report on CJMB
Hedge Funds Weigh In On Callan JMB
A hedge fund recently bought a new stake in Callan JMB stock. HighTower Advisors LLC acquired a new position in shares of Callan JMB Inc. (NASDAQ:CJMB – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 12,500 shares of the company’s stock, valued at approximately $56,000. HighTower Advisors LLC owned about 0.28% of Callan JMB as of its most recent SEC filing.
Callan JMB Company Profile
Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.
Further Reading
- Five stocks we like better than Callan JMB
- Investing in Travel Stocks Benefits
- ServiceNow’s $7 Billion Gamble: Panic or Opportunity?
- Insider Trades May Not Tell You What You Think
- Dell and HP Are Raising Prices—And Investors Should Take Note
- ETF Screener: Uses and Step-by-Step Guide
- Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026
Receive News & Ratings for Callan JMB Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Callan JMB and related companies with MarketBeat.com's FREE daily email newsletter.
